Literature DB >> 2954459

A shortened beta-hexosaminidase alpha-chain in an Italian patient with infantile Tay-Sachs disease.

G Zokaeem, J Bayleran, P Kaplan, P Hechtman, E F Neufeld.   

Abstract

Fibroblasts derived from a beta-hexosaminidase A (HexA)-deficient infant with clinically classic Tay-Sachs disease synthesized a precursor alpha-chain that was smaller than its normal counterpart. Fibroblasts from the infant's parents, who were consanguinous, produced both normal and mutant alpha-chains. The size difference, estimated to be 2-3 kilodaltons on the basis of sodium dodecyl sulfate-polyacrylamide-gel electrophoresis, persisted after removal of oligosaccharides with endo-H and is therefore attributable to a shortened polypeptide. The mutant alpha-chain did not undergo the further posttranslational modifications characteristic of its normal counterpart--i.e., synthesis of the mannose phosphate recognition marker, association with the beta-chain to give HexA, and proteolytic conversion to the mature form. Nor was it secreted, even in the presence of NH4Cl. Instead, it disappeared in the course of a 20-h chase. These results suggest that the mutant alpha-chain was trapped in an early biosynthetic compartment, either the endoplasmic reticulum or the cis-Golgi. The mutation appears to be different from all those previously described in patients with clinically classic Tay-Sachs disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954459      PMCID: PMC1684151     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

Review 1.  Biochemistry and genetics of gangliosidoses.

Authors:  K Sandhoff; H Christomanou
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 2.  Lysosomal enzymes and their receptors.

Authors:  K von Figura; A Hasilik
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

3.  Limited proteolysis of the beta-hexosaminidase precursor in a cell-free system.

Authors:  A Frisch; E F Neufeld
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

4.  Synthesis of beta-hexosaminidase in cell-free translation and in intact fibroblasts: an insoluble precursor alpha chain in a rare form of Tay-Sachs disease.

Authors:  R L Proia; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

5.  Faulty association of alpha- and beta-subunits in some forms of beta-hexosaminidase A deficiency.

Authors:  A d'Azzo; R L Proia; E H Kolodny; M M Kaback; E F Neufeld
Journal:  J Biol Chem       Date:  1984-09-10       Impact factor: 5.157

6.  Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.

Authors:  E Conzelmann; H J Kytzia; R Navon; K Sandhoff
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

7.  Association of alpha- and beta-subunits during the biosynthesis of beta-hexosaminidase in cultured human fibroblasts.

Authors:  R L Proia; A d'Azzo; E F Neufeld
Journal:  J Biol Chem       Date:  1984-03-10       Impact factor: 5.157

8.  Biosynthesis and transport of cathepsin D in cultured human fibroblasts.

Authors:  V Gieselmann; R Pohlmann; A Hasilik; K Von Figura
Journal:  J Cell Biol       Date:  1983-07       Impact factor: 10.539

9.  Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.

Authors:  H J Kytzia; U Hinrichs; I Maire; K Suzuki; K Sandhoff
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling.

Authors:  A Gonzalez-Noriega; J H Grubb; V Talkad; W S Sly
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

View more
  6 in total

1.  Processing of normal lysosomal and mutant N-acetylgalactosamine 4-sulphatase: BiP (immunoglobulin heavy-chain binding protein) may interact with critical protein contact sites.

Authors:  T M Bradford; M J Gething; R Davey; J J Hopwood; D A Brooks
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

2.  More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians.

Authors:  P Hechtman; F Kaplan; J Bayleran; B Boulay; E Andermann; M de Braekeleer; S Melançon; M Lambert; M Potier; R Gagné
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

3.  Structure of the GM2A gene: identification of an exon 2 nonsense mutation and a naturally occurring transcript with an in-frame deletion of exon 2.

Authors:  B Chen; B Rigat; C Curry; D J Mahuran
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

4.  Restriction fragment length polymorphisms associated with the factor VIII and factor IX genes in Polynesians.

Authors:  N S Van-de-Water; D Ridgway; P A Ockelford
Journal:  J Med Genet       Date:  1991-03       Impact factor: 6.318

5.  Natural history of infantile G(M2) gangliosidosis.

Authors:  Annette E Bley; Ourania A Giannikopoulos; Doug Hayden; Kim Kubilus; Cynthia J Tifft; Florian S Eichler
Journal:  Pediatrics       Date:  2011-10-24       Impact factor: 7.124

6.  Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.

Authors:  B H Paw; M M Kaback; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.